Profile
Jonathan McNeill is an executive who, according to SEC filings dated June 23, 2026, serves as President and Chief Operating Officer of Crescent Biopharma, Inc. The available filings indicate his role with Crescent Biopharma but do not provide additional publicly verifiable details about his background, education, or career history. In this position, he is responsible for overseeing the company’s day-to-day operations and implementing strategic initiatives in coordination with the CEO and other executives. Because information beyond the SEC filing context is not publicly disclosed in the provided source, this biography reflects only what is publicly documented in those filings.
| Role | President and COO |
|---|
| Notability | 45/100 |
|---|
Board memberships
Awards & honors
- Appointed President and COO of Crescent Biopharma, Inc. as of 2026-06-23 (per SEC filings).
Frequently Asked Questions
Who is McNeill Jonathan?
Jonathan McNeill is an executive who, according to SEC filings dated June 23, 2026, serves as President and Chief Operating Officer of Crescent Biopharma, Inc. The available filings indicate his role with Crescent Biopharma but do not provide additional publicly verifiable details about his background, education, or career history. In this position, he is responsible for overse…
How many SEC Form 4 filings has McNeill Jonathan submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Has McNeill Jonathan been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($370K) across all tracked filings.
Where can I see all of McNeill Jonathan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.